Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene) hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3- ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: Design, synthesis, QSAR analysis and anticancer activity

Journal Article
ملف مرفق: 
المرفقالحجم
PDF icon 1.pdf949.69 كيلوبايت